Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$267,360
-$42,390 QoQ
Shares Held
11,103
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#2,217
of 2,821 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Northern Financial Advisors Inc holds $8,250,442 across 7 Drug Manufacturers - General names. PFE ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,910 | $2,290,911 | |
| 2 | AMGN |
Amgen Inc
|
3,847 | $1,393,075 | |
| 3 | JNJ |
Johnson & Johnson
|
4,699 | $1,193,405 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
8,647 | $1,092,461 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,398 | $1,079,143 | |
| 6 | ABBV |
AbbVie Inc.
|
3,712 | $934,087 | |
| 7 | PFE |
Pfizer Inc
This page
|
11,103 | $267,360 |
All Filings in PFE
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $267,360 | 11,103 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $309,750 | 11,031 | Shares | Sole | 2026-04-28 | |
| 2025-09-30 | $283,312 | 11,119 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $214,693 | 8,857 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $238,702 | 9,420 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $353,114 | 13,310 | Shares | Sole | 2025-01-30 | |
| 2023-09-30 | $272,259 | 8,208 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $731,729 | 19,949 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $903,679 | 22,149 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $1,013,219 | 19,774 | Shares | Sole | 2023-01-30 | |
| No filing history on record for this holder in this stock. | ||||||